Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments against Staphylococcus aureus Infections
Author(s) -
Magdalena Czuban,
Sangeetha Srinivasan,
Nathan A. Yee,
Edgar Agustin,
Anna Koliszak,
Ethan Miller,
Irfan Khan,
Ilenis Quis,
Hasioory,
Christopher Motola,
Rudolf Volkmer,
Mariagrazia Di Luca,
Andrej Trampuž,
Maksim Royzen,
José M. Mejía Oneto
Publication year - 2018
Publication title -
acs central science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.893
H-Index - 76
eISSN - 2374-7951
pISSN - 2374-7943
DOI - 10.1021/acscentsci.8b00344
Subject(s) - prodrug , tetrazine , antibiotics , biomaterial , chemistry , staphylococcus aureus , daptomycin , bioorthogonal chemistry , candida albicans , pharmacology , in vivo , vancomycin , drug delivery , microbiology and biotechnology , medicine , combinatorial chemistry , biochemistry , bacteria , biology , click chemistry , organic chemistry , genetics
Systemic administration of antibiotics can cause severe side-effects such as liver and kidney toxicity, destruction of healthy gut bacteria, as well as multidrug resistance. Here, we present a bio-orthogonal chemistry-based strategy toward local prodrug concentration and activation. The strategy is based on the inverse electron-demand Diels-Alder chemistry between trans -cyclooctene and tetrazine and involves a biomaterial that can concentrate and activate multiple doses of systemic antibiotic therapy prodrugs at a local site. We demonstrate that a biomaterial, consisting of alginate hydrogel modified with tetrazine, is efficient at activating multiple doses of prodrugs of vancomycin and daptomycin in vitro as well as in vivo . These results support a drug delivery process that is independent of endogenous environmental markers. This approach is expected to improve therapeutic efficacy with decreased side-effects of antibiotics against bacterial infections. The platform has a wide scope of possible applications such as wound healing, and cancer and immunotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom